Salaam Karriem L MD - 19107 Philadelphia, PA

Business Name: Salaam Karriem L MD
Categorized In: Doctors
Address: 833 Chestnut St, Philadelphia, PA 19107
Phone Number: (215) 955-8363
Contact Person: Karriem Salaam
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Amy Lee Sproch M D - Philadelphia, PA 19107
Advanced Comprehensive Care Organization LLC - Philadelphia, PA 19107
Abdelmalek Mark MD - Philadelphia, PA 19107
Appel Shmuel MD - Philadelphia, PA 19107
Abraham Sheeja K MD - Philadelphia, PA 19107
Abbas Muhammad A MD - Philadelphia, PA 19107
Anderson William A MD - Philadelphia, PA 19107
Ahsan Shagufta MD - Philadelphia, PA 19107
Alfred I Dupont Hosp For Child - Philadelphia, PA 19107
Adamski David DO - Philadelphia, PA 19107
Advanced Neurology Assoc - Philadelphia, PA 19107
Aghai Zubairul H MD - Philadelphia, PA 19107
Abraham John A MD - Philadelphia, PA 19107
Abramov Ronnen DO - Philadelphia, PA 19107
Annesley Flanagan Stefanyszyn - Philadelphia, PA 19107
Taras, John S MD - Philadelphia, PA 19107
Alfred I Dupont Hosp-Children - Philadelphia, PA 19107
Adler Herbert DO - Philadelphia, PA 19107
Anthony J Cerone Jr Md - Philadelphia, PA 19107
Ann L Honebrink Md - Philadelphia, PA 19107

Salaam Karriem L MD provides professional Doctors from its single location at the coordinates 39.94981,-75.1552.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 833 Chestnut St, Philadelphia, Pennsylvania 19107 or contacted through representative Karriem Salaam at (215) 955-8363.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Salaam Karriem L MD through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.